Anthony Evnin is a Partner of Venrock, a venture capital firm, which he joined in 1974. He is currently a Director of AVEO Pharmaceuticals, Inc. and Infinity Pharmaceuticals, Inc., as well as Constellation Pharmaceuticals, Inc., a private company. Dr. Evnin was formerly a director of many other biotechnology companies. He serves as a Trustee of The Rockefeller University, as a Trustee of The Jackson Laboratory, as a Member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center, as a Member of the Board of Directors of the New York Genome Center, as a Member of the Board of Directors of the Albert and Mary Lasker Foundation, and as a Trustee Emeritus of Princeton University. Dr. Evnin received a B.A. from Princeton University and a Ph.D. in Chemistry from the Massachusetts Institute of Technology.